BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Are Peptides coming off of the FDA Category 2 list? A legal breakdown. RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Industry Update: Interim 503A and 503B Bulks Lists New Revisions